Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Jordan

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
British Journal of Cancer|February 16, 2013
Multiparameter DNA content analysis identifies distinct groups in primary breast cancerJ H S Dayal, M J Sales, W E Corver, et al.
British Journal of Cancer|February 20, 2014
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancerC L Downey, S A Simpkins, J White, et al.
British Journal of Cancer|January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancerL Baker, P R Quinlan, N Patten, et al.
Clinical Pharmacology and Therapeutics|September 25, 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populationsM A Province, M P Goetz, H Brauch, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
British Journal of Cancer|February 16, 2013
Multiparameter DNA content analysis identifies distinct groups in primary breast cancerJ H S Dayal, M J Sales, W E Corver, et al.
British Journal of Cancer|February 20, 2014
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancerC L Downey, S A Simpkins, J White, et al.
British Journal of Cancer|January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancerL Baker, P R Quinlan, N Patten, et al.
Clinical Pharmacology and Therapeutics|September 25, 2013
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populationsM A Province, M P Goetz, H Brauch, et al.
Pageof 3